XML 106 R88.htm IDEA: XBRL DOCUMENT v3.23.4
STOCK-BASED COMPENSATION - Narrative (Details)
$ / shares in Units, $ in Millions
1 Months Ended 5 Months Ended 7 Months Ended 12 Months Ended
Aug. 12, 2022
segment
individual
shares
Jul. 27, 2022
USD ($)
shares
Nov. 30, 2022
shares
Jan. 31, 2021
segment
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Jul. 27, 2022
USD ($)
$ / shares
Dec. 31, 2021
USD ($)
$ / shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Number of founders | individual 2            
Weighted average fair value of options granted in period (in dollars per share) | $ / shares         $ 3.58 $ 15.55 $ 15.55
Stock options, unrecognized compensation cost | $         $ 32.5   $ 9.4
Obagi and Milk Business Combinations              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Incremental stock based compensation expense | $   $ 18.3          
Fair value of equity awards in business combination | $   $ 47.7       $ 47.7  
Obagi Merger              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock options assumed in business combination (in shares)   5,906,300          
Milk Transaction              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock options assumed in business combination (in shares)   237,724          
Share-Based Payment Arrangement, Founder              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Stock options granted (in shares) 11,500,000            
Number of tranches | segment 4            
Predecessor Incentive Plan              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Maximum number of shares available for issuance       1,500,000      
Employee Stock | 2022 Incentive Award Plan              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Maximum number of shares available for issuance         16,134,716    
Anniversary period, annual increase in shares issued under plan         10 years    
Percentage increase in shares available for issuance         3.00%    
Shares reserved for future issuance (in shares)         2,749,579    
Restricted Stock Units (RSUs)              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock, unrecognized compensation cost | $             $ 12.4
Granted, weighted average grant date fair value (in dollars per share) | $ / shares           $ 38.90 $ 38.68
Restricted Stock Units (RSUs) | Obagi Merger              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Equity instruments assumed in business combination (in shares)   1,776,827          
Restricted Stock Units (RSUs) | Share-Based Payment Arrangement, Founder              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock units granted (in shares) 692,000            
Restricted Stock Units (RSUs) | Long-Term Incentive Awards              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock units granted (in shares)         694,537    
Vesting percentage         33.00%    
Restricted Stock Units (RSUs) | One-Tim Stock Grant              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Maximum number of shares available for issuance     10,000        
Award vesting period     3 years        
Restricted Stock Units (RSUs) | Predecessor Incentive Plan              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Award vesting period       5 years      
Number of annual installments | segment       5      
Award expiration period       10 years      
Restricted stock              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Restricted stock, unrecognized compensation cost | $         $ 11.4    
Compensation cost, weighted average service period         2 years 10 months 24 days    
Stock Appreciation Rights (SARs) | Milk Transaction              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Equity instruments assumed in business combination (in shares)   2,808,131          
Stock options              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Compensation cost, weighted average service period         4 years 9 months 18 days    
Stock options | Share-Based Payment Arrangement, Founder              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Award vesting period 6 years            
Stock options | Predecessor Incentive Plan              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Award vesting period       5 years      
Stock options | Predecessor Incentive Plan | Share-Based Payment Arrangement, Tranche Two              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Award vesting period       5 years      
Vesting percentage       75.00%      
Number of annual installments | segment       5      
Stock options | Predecessor Incentive Plan | Share-Based Payment Arrangement, Tranche One              
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]              
Award vesting period       3 months      
Vesting percentage       25.00%      
Number of quarterly installments | segment       4